[1]孙岩,鲁佳君,张煊,等.富血小板血浆软骨下骨注射治疗膝骨关节炎的研究进展[J].中医正骨,2022,34(05):58-62.
点击复制

富血小板血浆软骨下骨注射治疗膝骨关节炎的研究进展()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第34卷
期数:
2022年05期
页码:
58-62
栏目:
综述
出版日期:
2022-05-20

文章信息/Info

作者:
孙岩1鲁佳君1张煊1潘晓豪1郑凌歆1苏陈颖2金红婷3童培建3徐涛涛3
(1.浙江中医药大学第一临床医学院,浙江 杭州 310053; 2.温州医科大学附属第一医院,浙江 温州 325000; 3.浙江省中医院,浙江 杭州 310006)
关键词:
骨关节炎 富含血小板血浆 软骨下骨 注射 综述
摘要:
膝骨关节炎(knee osteoarthritis,KOA)是骨科临床常见的一种慢性退行性疾病,目前尚无明确能够阻止或逆转KOA进展的治疗方法。富血小板血浆(platelet rich plasma,PRP)是富含血小板的血浆制品,在修复软骨损伤方面具有显著优势。随着对软骨下骨研究的不断深入,许多学者开展了关于PRP软骨下骨注射治疗KOA的研究。本文对软骨下骨和PRP进行了概述,并从作用机制和临床疗效2个方面就PRP软骨下骨注射治疗KOA的研究进展进行了综述。

参考文献/References:

[1] ZHANG Y,CHEN X,TONG Y,et al.Development and pro-spect of intra-articular injection in the treatment of osteo-arthritis:a review[J].J Pain Res,2020,13:1941-1955.
[2] COLE B J,KARAS V,HUSSEY K,et al.Hyaluronic acid versus platelet-rich plasma:a prospective,double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis[J].Am J Sports Med,2017,45(2):339-346.
[3] KATZ J N,ARANT K R,LOESER R F.Diagnosis and treatment of hip and knee osteoarthritis:a review[J].JAMA,2021,325(6):568-578.
[4] COOK C S,SMITH P A.Clinical update:why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee[J].Curr Rev Musculoskelet Med,2018,11(4):583-592.
[5] FANG H,HUANG L,WELCH I,et al.Early changes of articular cartilage and subchondral bone in the DMM mouse model of osteoarthritis[J].Sci Rep,2018,8(1):2855.
[6] KWAN T S,LAJEUNESSE D,PELLETIER J P,et al.Targeting subchondral bone for treating osteoarthritis:what is the evidence?[J].Best Pract Res Clin Rheumatol,2010,24(1):51-70.
[7] CHEN P,HUANG L,MA Y,et al.Intra-articular platelet-rich plasma injection for knee osteoarthritis:a summary of meta-analyses[J].J Orthop Surg Res,2019,14(1):385.
[8] HUANG Y,LIU X,XU X,et al.Intra-articular injections of platelet-rich plasma,hyaluronic acid or corticosteroids for knee osteoarthritis:a prospective randomized controlled study[J].Orthopade,2019,48(3):239-247.
[9] TAN J,CHEN H,ZHAO L,et al.Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis:a meta-analysis of 26 randomized controlled trials[J].Arthroscopy,2021,37(1):309-325.
[10] BOCUN L,JING L,JIA L,et al.Effects of platelet-rich plasma injection for pain control and cartilage repair in knee osteoarthritis:a protocol for the systematic review and meta-analysis of randomized controlled trials in animal models[J].Medicine(Baltimore),2021,100(1):e24107.
[11] SANCHEZ M,FIZ N,GUADILLA J,et al.Intraosseous infiltration of platelet-rich plasma for severe knee osteo-arthritis[J].Arthrosc Tech,2014,3(6):e713-e717.
[12] FIZ N,PEREZ J C,GUADILLA J,et al.Intraosseous infiltration of platelet-rich plasma for severe hip osteoarthritis[J].Arthrosc Tech,2017,6(3):e821-e825.
[13] SUNDARAM K,VARGAS-HERNANDEZ J S,SANCHEZ T R,et al.Are subchondral intraosseous injections effective and safe for the treatment of knee osteoarthritis?A systematic review[J].J Knee Surg,2019,32(11):1046-1057.
[14] SHARMA A R,JAGGA S,LEE S S,et al.Interplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritis[J].Int J Mol Sci,2013,14(10):19805-19830.
[15] BURR D B.Anatomy and physiology of the mineralized tissues:role in the pathogenesis of osteoarthrosis[J].Osteoarthritis Cartilage,2004,12(Suppl A):S20-S30.
[16] MADRY H,VAN DIJK C N,MUELLER-GERBL M.The basic science of the subchondral bone[J].Knee Surg Sports Traumatol Arthrosc,2010,18(4):419-433.
[17] CASTANEDA S,ROMAN-BLAS J A,LARGO R,et al.Subchondral bone as a key target for osteoarthritis treatment[J].Biochem Pharmacol,2012,83(3):315-323.
[18] IMHOF H,SULZBACHER I,GRAMPP S,et al.Subchondral bone and cartilage disease:a rediscovered functional unit[J].Invest Radiol,2000,35(10):581-588.
[19] PAN J,WANG B,LI W,et al.Elevated cross-talk between subchondral bone and cartilage in osteoarthritic joints[J].Bone,2012,51(2):212-217.
[20] BARR A J,CAMPBELL T M,HOPKINSON D,et al.A systematic review of the relationship between subchondral bone features,pain and structural pathology in peripheral joint osteoarthritis[J].Arthritis Res Ther,2015,17:228.
[21] GOLDRING S R,GOLDRING M B.Changes in the osteochondral unit during osteoarthritis:structure,function and cartilage-bone crosstalk[J].Nat Rev Rheumatol,2016,12(11):632-644.
[22] ANDERSON-MACKENZIE J M,QUASNICHKA H L,STARR R L,et al.Fundamental subchondral bone changes in spontaneous knee osteoarthritis[J].Int J Biochem Cell Biol,2005,37(1):224-236.
[23] STUPINA T A,STEPANOV M A,TEPLEN'KII M P.Role of subchondral bone in the restoration of articular cartilage[J].Bull Exp Biol Med,2015,158(6):820-823.
[24] KAWCAK C E,MCILWRAITH C W,NORRDIN R W,et al.The role of subchondral bone in joint disease:a review[J].Equine Vet J,2001,33(2):120-126.
[25] HERMAN B C,CARDOSO L,MAJESKA R J,et al.Activation of bone remodeling after fatigue:differential response to linear microcracks and diffuse damage[J].Bone,2010,47(4):766-772.
[26] FELSON D T,CHAISSON C E,HILL C L,et al.The association of bone marrow lesions with pain in knee osteo-arthritis[J].Ann Intern Med,2001,134(7):541-549.
[27] ASTUR D C,DE FREITAS E V,CABRAL P B,et al.Evaluation and management of subchondral calcium phosphate injection technique to treat bone marrow lesion[J].Cartilage,2019,10(4):395-401.
[28] KAZAKIA G J,KUO D,SCHOOLER J,et al.Bone and cartilage demonstrate changes localized to bone marrow edema-like lesions within osteoarthritic knees[J].Osteoarthritis Cartilage,2013,21(1):94-101.
[29] TANAMAS S K,WLUKA A E,PELLETIER J P,et al.The association between subchondral bone cysts and tibial cartilage volume and risk of joint replacement in people with knee osteoarthritis:a longitudinal study[J].Arthritis Res Ther,2010,12(2):R58.
[30] NAM J,AGUDA B D,RATH B,et al.Biomechanical thre-sholds regulate inflammation through the NF-kappaB pathway:experiments and modeling[J].PLoS One,2009,4(4):e5262.
[31] 庞坚,曹月龙,石印玉.骨关节炎软骨下骨研究进展[J].中国骨伤,2011,24(8):702-704.
[32] FUNCK-BRENTANO T,COHEN-SOLAL M.Subchondral bone and osteoarthritis[J].Curr Opin Rheumatol,2015,27(4):420-426.
[33] FOSTER T E,PUSKAS B L,MANDELBAUM B R,et al.Platelet-rich plasma:from basic science to clinical applications[J].Am J Sports Med,2009,37(11):2259-2272.
[34] ORYAN A,ALIDADI S,MOSHIRI A.Platelet-rich plasma for bone healing and regeneration[J].Expert Opin Biol Ther,2016,16(2):213-232.
[35] ZACHER J.Efficacy of intra-articular injection of PRP[J].Orthopade,2014,43(10):940-942.
[36] EVERTS P,ONISHI K,JAYARAM P,et al.Platelet-rich plasma:new performance understandings and therapeutic considerations in 2020[J].Int J Mol Sci,2020,21(20):7794.
[37] FADADU P P,MAZZOLA A J,HUNTER C W,et al.Review of concentration yields in commercially available platelet-rich plasma(PRP)systems:a call for PRP standardization[J/OL].Reg Anesth Pain Med,2019[2021-06-16].https://pubmed.ncbi.nlm.nih.gov/30992411/.
[38] MALANGA G,JAYARAM P.Need for proper classification of PRP:letter to the editor[J].Am J Sports Med,2017,45(6):NP23-NP24.
[39] LEVY D M,PETERSEN K A,SCALLEY V M,et al.Injections for knee osteoarthritis:corticosteroids,viscosupplementation,platelet-rich plasma,and autologous stem cells[J].Arthroscopy,2018,34(5):1730-1743.
[40] TANG J Z,NIE M J,ZHAO J Z,et al.Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis:a meta-analysis[J].J Orthop Surg Res,2020,15(1):403.
[41] HAN Y,HUANG H,PAN J,et al.Meta-analysis comparing platelet-rich plasma vs hyaluronic acid injection in patients with knee osteoarthritis[J].Pain Med,2019,20(7):1418-1429.
[42] LAUDY A B,BAKKER E W,REKERS M,et al.Efficacy of platelet-rich plasma injections in osteoarthritis of the knee:a systematic review and meta-analysis[J].Br J Sports Med,2015,49(10):657-672.
[43] YUAN X L,MENG H Y,WANG Y C,et al.Bone-cartilage interface crosstalk in osteoarthritis:potential pathways and future therapeutic strategies[J].Osteoarthritis Cartilage,2014,22(8):1077-1089.
[44] KRUGER J P,HONDKE S,ENDRES M,et al.Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells[J].J Orthop Res,2012,30(6):845-852.
[45] XU Z,YIN W,ZHANG Y,et al.Comparative evaluation of leukocyte-and platelet-rich plasma and pure platelet-rich plasma for cartilage regeneration[J].Sci Rep,2017,7:43301.
[46] ANITUA E,SANCHEZ M,NURDEN A T,et al.Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients[J].Rheumatology(Oxford),2007,46(12):1769-1772.
[47] VASINA E M,CAUWENBERGHS S,FEIJGE M A,et al.Microparticles from apoptotic platelets promote resident macrophage differentiation[J].Cell Death Dis,2011,2(9):e211.
[48] TOHIDNEZHAD M,WRUCK C J,SLOWIK A,et al.Role of platelet-released growth factors in detoxification of reactive oxygen species in osteoblasts[J].Bone,2014,65:9-17.
[49] LIU-BRYAN R,TERKELTAUB R.Emerging regulators of the inflammatory process in osteoarthritis[J].Nat Rev Rheumatol,2015,11(1):35-44.
[50] HURLEY E T,YASUI Y,GIANAKOS A L,et al.Limited evidence for adipose-derived stem cell therapy on the treatment of osteoarthritis[J].Knee Surg Sports Traumatol Arthrosc,2018,26(11):3499-3507.
[51] DOYLE E C,WRAGG N M,WILSON S L.Intraarticular injection of bone marrow-derived mesenchymal stem cells enhances regeneration in knee osteoarthritis[J].Knee Surg Sports Traumatol Arthrosc,2020,28(12):3827-3842.
[52] MUINOS-LOPEZ E,DELGADO D,SANCHEZ P,et al.Modulation of synovial fluid-derived mesenchymal stem cells by intra-articular and intraosseous platelet rich plasma administration[J/OL].Stem Cells Int,2016[2021-06-16].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080490/.
[53] SANCHEZ M,DELGADO D,SANCHEZ P,et al.Platelet rich plasma and knee surgery[J/OL].Biomed Res Int,2014[2021-06-16].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167644/.
[54] LYCHAGIN A,LIPINA M,GARKAVI A,et al.Intraosseous injections of platelet rich plasma for knee bone marrow lesions treatment:one year follow-up[J].Int Orthop,2021,45(2):355-363.
[55] SANCHEZ M,DELGADO D,SANCHEZ P,et al.Combination of intra-articular and intraosseous injections of platelet rich plasma for severe knee osteoarthritis:a pilot study[J/OL].Biomed Res Int,2016[2021-06-16].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947638/.
[56] SANCHEZ M,DELGADO D,POMPEI O,et al.Treating severe knee osteoarthritis with combination of intra-osseous and intra-articular infiltrations of platelet-rich plasma:an observational study[J].Cartilage,2019,10(2):245-253.
[57] 苏柯,白玉明,王军,等.关节内联合松质骨内注射富血小板血浆治疗膝骨关节炎的临床观察[J].中华关节外科杂志(电子版),2017,11(5):471-476.
[58] SU K,BAI Y,WANG J,et al.Comparison of hyaluronic acid and PRP intra-articular injection with combined intra-articular and intraosseous PRP injections to treat patients with knee osteoarthritis[J].Clin Rheumatol,2018,37(5):1341-1350.
(收稿日期:2021-08-18 本文编辑:吕宁)

相似文献/References:

[1]樊庆阳,任凯晶.定制3D打印切模辅助全膝关节置换术治疗 膝骨关节炎合并股骨干骨折畸形愈合[J].中医正骨,2015,27(11):37.
[2]刘晓雅,孙永强,刘国杰.主动快速康复锻炼对全膝关节置换术后关节活动度的影响[J].中医正骨,2015,27(09):73.
[3]郑春松,叶蕻芝,李西海,等.透骨消痛胶囊中补肾柔肝药和活血祛风药治疗 骨关节炎作用方式的计算机模拟比较[J].中医正骨,2015,27(07):6.
 ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(补肾柔肝)drugs versus Huoxue Qufeng(活血祛风)drugs contained in Tougu Xiaotong Jiaonang(透骨消痛胶囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):6.
[4]宋兵华,孙俊英,倪增良,等.全膝关节置换术前CT测量股骨后髁角的临床意义[J].中医正骨,2015,27(07):38.
[5]郑春松,叶蕻芝,李西海,等.独活寄生汤含药血清对白细胞介素1β诱导的 退变关节软骨细胞中基质金属蛋白酶 和环氧化酶2表达的影响[J].中医正骨,2015,27(12):1.
 ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Impact of Duhuo Jisheng Tang(独活寄生汤)medicated serum on expression of matrix metalloproteinase and cyclooxygenase 2 in degenerative articular chondrocytes induced by interleukin-1 beta[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):1.
[6]王金良,孙京涛,李玲,等.骨水泥联合螺钉修复全膝关节置换术中 胫骨平台内侧骨缺损[J].中医正骨,2015,27(12):55.
[7]冯荣,王平,李炳奇,等.铍针刺络拔罐结合中药口服治疗膝骨关节炎合并 原发性血小板增多症1例[J].中医正骨,2015,27(12):73.
[8]蔡云仙.围手术期耳穴按压联合平衡针疗法 在全膝关节置换术后镇痛中的应用[J].中医正骨,2015,27(06):41.
[9]张荣,王健.人工全膝关节置换术的围手术期心理护理[J].中医正骨,2015,27(05):77.
[10]喻长纯,杨明路,王战朝.不同手术方式治疗胫骨平台骨折畸形愈合的体会[J].中医正骨,2015,27(03):37.
[11]孟维娜,明立功,王新德,等.关节镜下清理联合腓骨近1/3段截骨治疗膝骨关节炎[J].中医正骨,2015,27(11):40.
[12]明立功,孟维娜,王新德,等.腓骨近端截骨治疗内侧间室膝骨关节炎的近期疗效观察[J].中医正骨,2015,27(10):25.
[13]张杰,王人彦,张玉柱.膝骨关节炎的治疗进展[J].中医正骨,2015,27(10):68.
[14]梁朝,蔡静怡,闫立,等.针刀疗法改善膝骨关节炎早期疼痛症状的疗效评价[J].中医正骨,2015,27(09):9.
 LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):9.
[15]王建武,党建军,李强,等.四联疗法治疗膝骨关节炎[J].中医正骨,2015,27(08):44.
[16]刘红娟,郭会利,郭树农.云克联合中药治疗膝骨关节炎的护理[J].中医正骨,2015,27(08):75.
[17]陈卫衡.探索建立系统的膝骨关节炎中医临床科研范式 和理论体系[J].中医正骨,2015,27(07):1.
[18]帅波,沈霖,杨艳萍,等.加味青娥丸治疗膝骨关节炎的作用机制研究[J].中医正骨,2015,27(07):15.
 SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):15.
[19]梅其杰,袁长深,段戡,等.壮药骨痹方烫熨联合运动疗法治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):27.
 MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):27.
[20]王丹辉,张燕,刘丽娟,等.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 关节腔注射联合中药薰洗治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):31.
 WANG Danhui,ZHANG Yan,LIU Lijuan,et al.Clinical study on intra-articular injection of TypeⅡrecombinant human tumor necrosis factor receptor-Fc fusion protein combined with Chinese herbal steaming and washing therapy for treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):31.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金项目(81904223); 浙江省医药卫生科技计划项目(2020KY659); 骨质疏松和骨矿盐疾病中青年医生优才培养计划暨白求恩·石药骨质疏松科研基金项目(G-X-2020-1107-17); 浙江中医药大学校级中青年科研创新基金项目(KC201933); 浙江中医药大学校级科研基金项目(2019ZR01) 通讯作者:徐涛涛 E-mail:xut@zcmu.edu.cn
更新日期/Last Update: 1900-01-01